Launch week offerEnds in00h00m00s

annual Promonthly Pro

Nirbhay Kumar

Professor

George Washington University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

About

Professor Nirbhay Kumar serves at George Washington University in the United States. His research focuses on malaria, particularly in the areas of vaccine development and immunogenicity. Recent contributions include evaluations of DNA vaccine combinations and monoclonal antibodies targeting Plasmodium species. He is also involved in addressing vaccine hesitancy and assessing diagnostic methods for effective malaria control.

Articles (12)

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (3)

Takafumi Tsuboi

Senior Research Fellow

Ehime University

JAPAN

View details

Abhai Tripathi

Faculty

Johns Hopkins University

UNITED STATES

View details

Joseph Vinetz

Professor

Yale University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nirbhay Kumar

Research Interests

Make your next move.

Explore related searches

About

Articles (12)

No single magic bullet: the case for combined interventions for global malaria elimination and eradication

Pfs230 Domains 7–10 Encoded by DNA Vaccines Induce Potent Complement-Independent Transmission-Blocking Antibody Against Plasmodium falciparum

Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax

Transmission-reducing and -enhancing monoclonal antibodies against Plasmodium vivax gamete surface protein Pvs48/45

Correction: Cao et al. Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission. Vaccines 2022, 10, 1134

A Novel Ex Vivo Assay to Evaluate Functional Effectiveness of Plasmodium vivax Transmission-Blocking Vaccine Using Pvs25 Transgenic Plasmodium berghei

Novel Therapeutics for Malaria

Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences

Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission

Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma—Progress and Challenges

Addressing Parental Vaccine Hesitancy towards Childhood Vaccines in the United States: A Systematic Literature Review of Communication Interventions and Strategies

Evaluation of Malaria Diagnostic Methods as a Key for Successful Control and Elimination Programs

Collaborators (3)

Takafumi Tsuboi

Abhai Tripathi

Joseph Vinetz

Make your next move.